SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 16th, 2022 • Arcadia Biosciences, Inc. • Agricultural production-crops • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 12, 2022 between Arcadia Biosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
PRE-FUNDED COMMON STOCK PURCHASE WARRANT arcadia biosciences, inc.Pre-Funded Common Stock Purchase Warrant • August 16th, 2022 • Arcadia Biosciences, Inc. • Agricultural production-crops
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 16, 2022 (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Arcadia Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
STRICTLY CONFIDENTIAL Arcadia Biosciences, Inc.Exclusive Agency Agreement • August 16th, 2022 • Arcadia Biosciences, Inc. • Agricultural production-crops • New York
PLACEMENT AGENT PREFERRED INVESTMENT OPTION arcadia biosciences, inc.Security Agreement • August 16th, 2022 • Arcadia Biosciences, Inc. • Agricultural production-crops
THIS PLACEMENT AGENT PREFERRED INVESTMENT INVESTMENT OPTION (the “Preferred Investent Option”) certifies that, for value received, ________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 16, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 12, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Arcadia Biosciences, Inc., a Delaware corporation (the “Company”), up to ________ shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of the Company’s common stock (the “Common Stock”). The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b). This Preferred Investment Option is being issued pursuant to that certain engagement letter, dated as of August 12, 2
